This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
News|Articles|July 28, 2025
AAP recommends all healthy children 6 months or older receive influenza vaccine
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Morgan Ebert, Executive Editor
Of the 253 influenza-related pediatric deaths through June 21, 2025, 42.7% occurred in children without a high-risk medical condition.
Advertisement
Advertisement
The American Academy of Pediatrics (AAP), an organization made up of more than 67,000 pediatricians, pediatric medical subspecialists, and surgical specialists, has released its influenza vaccine recommendations for the 2025-2026 season.1
Related to this article
The AAP recommends annual flu vaccination for all children aged 6 months and older and updates antiviral guidance for the 2026–2027 season.
The AAP's 2026-2027 policy recommends universal vaccination for infants 6-23 months and a risk-based single dose for children 2-18 years.
AAP guidance expands RSV immunization eligibility for children aged 8 through 19 months at high risk of severe disease.
Starting antiviral therapy within 48 hours of influenza symptom onset was associated with an 81% lower hospitalization risk in children.
Melissa Wallach, MD, FAAP, discusses what pediatricians should know about updated screening, supplementation, and treatment recommendations for iron deficiency.
XOCOVA gives pediatricians a new oral option to help prevent COVID-19 after exposure in adolescents aged 12 years and older.
Five rapid developments — new mRNA flu vaccine, CDC director, ACIP/NVAC charters, a vaccine order, and an HHS RFI — roil the 2026 schedule.
Advertisement
Advertisement